The average age across all cohorts was 57.4 years, from 55.5 to 62.6 years
Acknowledgments We thank all participants for their time and commitment to this study
Its not safe or effective, according to the Food and Drug Administration (FDA), and it may lead to serious health problems
Get Personalized Care from Our Weight Loss Specialist Meet Dr
in trial data, this effect appears to be offset by the concurrent GLP-1 and GIP activity, though the precise interplay in humans remains under investigation
Early signs include reduced appetite, smaller portion sizes, decreased food cravings, less interest in high-calorie snacks, and what many describe as quieter "food noise." These appetite and behavioral changes typically precede visible weight loss by several weeks